A group of advisers to the Centers for Disease Control and Prevention is preparing to vote on whether the agency should scrap ...

The nation's top vaccine advisory panel is expected to debate on Thursday whether to delay the first dose of the hepatitis B ...

As RFK Jr.'s new vaccine panel ponders changing the hepatitis B vaccination schedule, some doctors recall past patients, ...

As hepatitis B research progresses, achieving higher functional cure rates is becoming more feasible. It is vital that ...

The three-dose hepatitis B vaccine has a long track record of safety, but rolling back recommendations could leave kids ...

Of the 723 people with Fibrosis-4 Index scores greater than 3.25, indicating advanced fibrosis, and 587 people with diagnosed ...

The CDC's Advisory Committee on Immunization Practices will discuss hepatitis b shots for newborns and updates to ...

The shake-up that resulted in Kirk Milhoan, MD, PhD, leading the Advisory Committee on Immunization Practices (ACIP) has ...

A combination treatment involving tobevibart and elebsiran significantly improved disease activity in adults with chronic ...

Despite untreated HBV being linked to earlier mortality, higher all-cause and liver-related death, and a 10% to 25% lifetime risk of developing hepatocellular carcinoma (HCC), only 29% of qualifying ...

In this video, Mark Sulkowski, MD, discusses the AASLD updated practice guidelines on the treatment of patients with chronic hepatitis B.